Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
A drug solution and drug technology, applied in medical science, pharmaceutical formulations, preparations for in vivo experiments, etc., can solve the problems of epileptic seizure activity cessation and prolongation
Inactive Publication Date: 2009-04-01
P·D·温施
View PDF7 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
iv. Initiation of treatment with diazepam injections results in prolonged cessation of seizure activity
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0343] A sterile aqueous solution containing atracurium besylate (10 mg) and fluorescein (10 mg) per milliliter (mL), wherein the pH of the solution was adjusted to 3.5 with besylate.
Embodiment 2
[0344]Sterile aqueous solution containing atracurium besylate (10 mg), benzyl alcohol (10 mg) and fluorescein (10 mg) per mL, wherein the pH of the solution was adjusted to 3.5 with benzenesulfonic acid.
Embodiment 3
[0345] Sterile aqueous solution containing rocuronium bromide (10 mg), sodium acetate trihydrate (2 mg), sodium chloride (3.3 mg) and fluorescein (50 mg) per mL, wherein the pH of the solution was adjusted to 4.0 with acetic acid .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
| Property | Measurement | Unit |
|---|---|---|
| Concentration | aaaaa | aaaaa |
| Concentration | aaaaa | aaaaa |
| Concentration | aaaaa | aaaaa |
Login to View More
Abstract
The invention is directed to pharmaceutical compositions comprising colored solutions, colored emulsions, or colored powders of injectable pharmaceuticals wherein said pharmaceuticals are selected from the group consisting of muscle relaxants, hypnotics, induction agents, and anticholinergics. The formulations of the present invention may all be colored using fluorescein. Different colors may be achieved by either varying the concentration of fluorescein, or by combining fluorescein with another dye. The invention is also directed to methods involving the use of said pharmaceutical compositions.
Description
technical field [0001] The present invention relates to compositions and methods comprising colored solutions of injectable drugs and their pharmaceutically acceptable salts. Background technique [0002] The safety of drug delivery is of paramount importance in healthcare settings. It is estimated that 7000 Americans die each year from medication errors (1999 Institute of Medicine report, "To Erris Human: Building a Safer Health System,"). [0003] In the practice of anesthesiology, physicians and nurse practitioners prepare syringes of drugs that are used throughout the induction and maintenance of general anesthesia, sedation, and conscious sedation. Prepare the syringe by drawing the drug from a clear glass vial into a plastic disposable syringe. In current practice, implementers often place a pre-printed label or hand-crafted logo on the syringe, which details the contents. Labels are pre-printed with the drug name and color-coded by drug class. However, color-coded...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): A61K49/00A61B5/00A61B8/00
Inventor P·D·温施
Owner P·D·温施

